FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017459623> ?p ?o ?g. }

• W2017459623 endingPage "25" @default.
• W2017459623 startingPage "17" @default.
• W2017459623 abstract "The Journal of Clinical Pharmacology and The Journal of New DrugsVolume 7, Issue 1 p. 17-25 Tranquilizers in the Management of Alcoholics: A Review of the Literature to 1964. Part II DANIEL BENOR M.D., DANIEL BENOR M.D. Kansas City, Kans. Dr. Benor was Mental Health Fellow at UCLA, Neuropsychiatric Institute, now Intern at the University of Kansas Medical Center, Kansas City, Kans.Search for more papers by this authorKEITH S. DITMAN M.D., KEITH S. DITMAN M.D. Los Angeles, Calif. Dr. Ditman is Director, Alcoholism Research Clinic, UCLA Center for the Health Sciences, Los Angeles, Calif.Search for more papers by this author DANIEL BENOR M.D., DANIEL BENOR M.D. Kansas City, Kans. Dr. Benor was Mental Health Fellow at UCLA, Neuropsychiatric Institute, now Intern at the University of Kansas Medical Center, Kansas City, Kans.Search for more papers by this authorKEITH S. DITMAN M.D., KEITH S. DITMAN M.D. Los Angeles, Calif. Dr. Ditman is Director, Alcoholism Research Clinic, UCLA Center for the Health Sciences, Los Angeles, Calif.Search for more papers by this author First published: January‐February 1967 https://doi.org/10.1002/j.1552-4604.1967.tb00025.xCitations: 4 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Albert, S. N., et al.: The use of chlorpromazine in the treatment of acute alcoholism. Med. Ann. D. C. 23: 245 (1954). 2 Armour, P. S.: Management of acute alcohol and barbiturate withdrawal states. Western Med. 4: 369 (1963). 3 Avol, M., and Vogel, P. J.: Treatment of delirium tremens with reserpine. J.A.M.A. 159: 1516 (1955). 4 Ayd, F. J., Jr.: A critical appraisal of chlordiazepoxide. J. Neuropsychiat. 3: 177 (1962). 5 Azima, H., Arthurs, D., and Silver, A.: The effects of chlordiazepoxide in anxiety states. A multi-blind study. Canad. Psych. Assoc. J. 7: 44 (1961). 6 Bardenat, C., Sutter, J. M., and Escoute, R.: Remarkable efficiency of intravenous meprobamate in the treatment of delirium tremens. (Fr.) Ann. Med. Psychol. 1: 951 (1961). 7 Barrett, O., Jr.: Convulsive seizures after administration of chlorpromazine. J.A.M.A. 166: 1986 (1958). 8 Barsa, J. A., and Saunders, J. C.: Chlordiazepoxide in the treatment of psychotics with convulsive disorders. Dis. Nerv. Syst. 23: 106 (1961). 9 Bartholomew, A. A.: Perphenazine (Trilafon) in immediate management of acutely disturbed chronic alcoholics. Med. J. Australia 1: 812 (1963). 10 University of Texas Medical Branch: Symposium on newer antidepressant and other psychotropic drugs. Dis. Nerv. Syst. 21 (Suppl.): 7 (1960). 11 Becker, G. S., and Israel, P.: Integrated drug and psychotherapy in the treatment of alcoholism. Quart. J. Stud. Alc. 22: 610 (1961). 12 U.C.L.A. Neuropsychiatric Institute: Symposium on chlordiazepoxide, a scientific meeting. Dis. Nerv. Syst. 22(Suppl.) (1961). 13 Beerman, H. M.: A controlled study of diazepam in psychiatric outpatients. Amer. J. Psychiat. 120: 870 (1964). 14 Bercel, N.: Chlordiazepoxide as an anticonvulsant. Dis. Nerv. Syst. 22: 17 (1961). 15 Brill, N. Q., Koegler, R. R., Epstein, L. J., and Forgy, E. W.: Controlled study of psychiatric outpatient treatment. Arch. Gen. Psych. 10: 581 (1964). 16 Brock, J. T., and Dyken, M.: The anticonvulsant activity of chlordiazepoxide and RO 5-2807. Neurology 13: 59 (1963). 17 Chesrow, E. J., et al.: The use of chlordiazepoxide in the alcoholic patient: a clinical study of forty cases. J. Amer. Geriat. Soc. 10: 264 (1962). 18 Chesrow, E. J., et al.: Adjunctive treatment of the chronic alcoholic with hexacyclonate sodium. Illinois Med. J. 121: 546 (1962). 19 Cohen, N. H., McAuliffe, M., and Aird, R. B.: “Startle” epilepsy treated with chlordiazepoxide. Dis. Nerv. Syst. 22 (Suppl.): 20 (1961). 20 Cohen, S., Ditman, K. S., and Mooney, H. B.: Effect of Trifluoperazine on Some Symptoms Common Among Skid Row Alcoholics. In Trifluoperazine, Clinical and Pharmacological Aspects. Philadelphia, Lea & Febiger, 1958, p. 189. 21 Cohen, S., Ditman, K. S., Mooney, H. B., and Whittlesey, J. R. B.: Prothipendyl (Timovan) in the treatment of alcoholism: preliminary report. J. New Drugs 1: 235 (1961). 22 Cohen, S.: Thioridazine (Mellaril), a review. Mind 2: 134 (1964). 23 Costa, J. S., and Hoffman, E. T.: The use of trifluoperazine for acute alcoholism. Med. Ann. D. C. 29: 556 (1960). 24 Cummins, J. F., and Friend, D. G.: Use of chlorpromazine in chronic alcoholics. Amer. J. Med. Sci. 227: 561 (1954). 25 D'Agostino, A., and Schultz, J. D.: Clinical experience with chlordiazepoxide in acute alcoholism. Psychosomatics 2: 1 (1961). 26 DiFrancesco, A.: Diazepam, a new tranquilizer. Amer. J. Psychiat. 119: 989 (1963). 27 Ewing, J. A.: The first phase of alcoholic rehabilitation: report of a controlled study with benactyzine, paraldehyde, and pyridoxine. Quart. J. Stud. Alc. 21: 68 (1960). 28 Fazekas, J. F., Shea, J., and Rea, E.: Use of chlorpromazine in the management of acute and postalcoholic states. Int. Rec. Med. and G. P. Clin. 168: 333 (1965). 29 Fazekas, J. F., Schultz, J. D., Sullivan, P. D., and Shea, J. G.: Management of acutely disturbed patients with promazine. J.A.M.A. 161: 46 (1956). 30 Fazekas, J. F., Shea, J. G., Ehrmantraut, W. R., and Alman, R. W.: Convulsant action of phenothiazine derivatives. J.A.M.A. 165: 1241 (1957). 31 Feldman, P. E.: An analysis of the efficacy of diazepam. J. Neuropsychiat. 3: S62 (1962). 32 Figurelli, F. A.: Delirium tremens: reduction of mortality and morbidity with promazine. J.A.M.A. 166: 747 (1958). 33 Figurelli, F. A., Davis, R., and Figurelli, J.: Severe and complicated delirium tremens: results of promazine therapy in a selected group. Med. Times 90: 1347 (1962). 34 Forney, R. B., Hulpieu, H. R., and Hughes, F. W.: The comparative enhancement of the depressant action of alcohol by eight representative ataractic and analgesic drugs. Experientia 18: 465 (1962). 35 Friedhoff, A. J., and Zitrin, A.: A comparison of the effects of paraldehyde and chlorpromazine in delirium tremens. New York J. Med. 59: 1060 (1959). 36 Goldman, D., and Schynoll, G.: The effect of chlordiazepoxide on convulsive disorder. Dis. Nerv. Syst. 25: 1 (1964). 37 Graham, R. C. B., Lu, F. C., and Allmark, M. G.: Combined effect of tranquilizing drugs and alcohol on rats. Fed. Proc. (Part I) 16: 302 (1957). 38 Greenberg, L. A., et al.: An evaluation of meprobamate in the treatment of alcoholism. Ann. New York Acad. Sci. 67: 816 (1957). 39 Greenfield, A. R.: Perphenazine in the management of acute alcoholic intoxication. Curr. Therap. Res. 3: 217 (1961). 40 Gruenwald, F., Hanlon, T. E., Wachsler, S., and Kurland, A. A.: A comparative study of promazine and trifluopromazine in the treatment of acute alcoholism. Dis. Nerv. Syst. 21: 32 (1960). 41 Gunter, M. J.: Convulsive seizures following administration of chlorpromazine. Ohio Med. J. 54: 51 (1958). 42 Haden, H. H., Jr., and Fowler, R. D.: Prozine as an adjunct to psychotherapy with alcoholic outpatients in the withdrawal stage. Quart. J. Stud. Alc. 23: 442 (1962). 43 Hankoff, L. S., Kaye, N. E., Engelhardt, D. M., and Freedman, N.: Convulsions complicating ataractic therapy, their incidence and theoretical implications. New York J. Med. 57: 2967 (1957). 44 Hare, H. P., Jr.: A comparison of diazepam, chlorpromazine and a placebo in psychiatric practice. J. New Drugs 3: 233 (1963). 45 Hart, W. T.: A comparison of promazine and paraldehyde in 175 cases of alcohol withdrawal. Amer. J. Psychiat. 118: 363 (1961). 46 Heilizer, F.: A critical review of some published experiments with chlorpromazine in schizophrenic, neurotic and normal humans. J. Chron. Dis. 11: 102 (1960). 47 Vilkin, M. I., and Lomas, J. B.: Clinical experience with diazepam in general psychiatric practice. J. Neuropsychiat. 3 (Suppl.): 139 (1962). 48 Ingelfinger, F. J.: The Alimentary Tract: General Considerations. In T. R. Harrison, et al., eds.: Principles of Internal Medicine. New York, McGraw-Hill, 1962, pp. 1577–1581. 49 Jenner, F. A., Kerry, R. J., and Parkin, D.: A controlled trial of methaminodiazepoxide in the treatment of anxiety in neurotic patients. J. Ment. Sci. 107: 575 (1961). 50 Jenner, F. A., Kerry, R. J., and Parkin, D.: A controlled comparison of methaminodiazepoxide and amylobarbitone in the treatment of anxiety in neurotic patients. J. Ment. Sci. 107: 583 (1961). 51 Kaim, S. C., and Rosenstein, I. N.: Anticonvulsant properties of a new psychotherapeutic drug. Dis. Nerv. Syst. 21 (Suppl.): 46 (1960). 52 Kaim, S. C., and Rosenstein, I. N.: Experience with chlordiazepoxide in the management of epilepsy. J. Neuropsychiat. 3: 12 (1961). 53 Karolus, H. A.: Chlordiazepoxide in the treatment of acute alcoholism: a preliminary report. Illinois Med. J. 120: 96 (1961). 54 Kerry, R. J., and Jenner, F. A.: A double-blind crossover comparison of diazepam with chlordiazepoxide in the treatment of neurotic anxiety. Psychopharmacologia 3: 302 (1962). 55 Kissen, M. D.: The treatment of alcoholics. Quart. J. Stud. Alc. 22(Suppl. 1): 101 (1961). 56 Kopmann, E., and Hughes, F. W.: Potentiating effect of alcohol on tranquilizers and other central depressants. A. M. A. Arch. Gen. Psychiat. 1: 7 (1959). 57 Laties, V. G., et al.: A controlled trial of chlorpromazine and promazine in the management of delirium tremens. Quart. J. Stud. Alc. 19: 238 (1958). 58 Laties, V. G., and Weiss, B.: A critical review of the efficacy of meprobamate in the treatment of anxiety. J. Chron. Dis. 7: 500 (1958). 59 Lawrence, F. E., et al.: Chlordiazepoxide in the treatment of alcoholism. J. Neuropsychiat. 2: 93 (1960). 60 Lawrence, F. E.: The outpatient management of the alcoholic. Quart. J. Stud. Alc. (Suppl.) 22: 117 (1961). 61 Lawton, M., and Cahn, B.: The effects of diazepam and alcohol on psychomotor performance. J. Nerv. Ment. Dis. 136: 550 (1963). 62 LeVann, L. F.: Chlordiazepoxide, a tranquilizer with anticonvulsant properties. Canad. M. A. J. 86: 123 (1962). 63 LaVeck, G. G., and Buckley, P.: The use of tranquilizer drugs in retarded children. J. Chron. Dis. 13: 174 (1961). 64 Librium. Medical Letter 5: 93 (1963). Also Ibid. 2:37 (1960). 65 Livingston, S., Pauli, L., and Murphy, J. B.: Ineffectiveness of chlordiazepoxide hydrochloride in epilepsy. J.A.M.A. 177: 243 (1961). 66 Marquis, D. G., et al.: Experimental studies of behavioral effects of meprobamate on normal subjects. Ann. New York Acad. Sci. 67: 701 (1957). 67 Martens, S.: Clinical trial of emylcamate, a new internuncial blocking tranquilizer. A double-blind study in alcoholic outpatients. Quart. J. Stud. Alc. 21: 223 (1960). 68 Miller, A. I., D'Agostino, A., and Minsky, R.: Effects of combined chlordiazepoxide and alcohol in man. Quart. J. Stud. Alc. 24: 9 (1963). 69 Miller, J. G.: Objective measurements of the effects of drugs on driver behavior. J.A.M.A. 179: 102 (1962). 70 Mitchell, E. H.: Chlorpromazine in the treatment of acute alcoholism. Amer. J. Med. Sci. 229: 363 (1955). 71 Mitchell, E. H.: Treatment of acute alcoholism with promazine. J.A.M.A. 161: 44 (1956). 72 Mooney, H. B., Ditman, K. S., and Cohen, S.: Chlordiazepoxide in the treatment of alcoholics. Dis. Nerv. Syst. 22: 44 (1961). 73 Mooney, H. B., Cohen, S., Ditman, K. S., and Whittlsey, J. R. B.: Methocarbamol (Robaxin) in the treatment of alcoholics. J. New Drugs 1: 276 (1961). 74 Mooney, H. B., Cohen, S., Ditman, K. S., and MacAndrew, C.: Methoxydone in the treatment of chronic alcoholics. J. New Drugs 1: 35 (1961). 75 Murray, N.: Covert effects of chlordiazepoxide therapy. J. Neuropsychiat. 3: 168 (1962). 76 Pilkington, T. L.: Comparative effects of Librium and Taractan on behavior disorders of mentally retarded children. Dis. Nerv. Syst. 22: 573 (1961). 77 Raymond, M. J., Lucas, C. J., Beesley, M. L., and O'Connell, B. A.: A trial of five tranquilizing drugs in psychoneurosis. Brit. Med. J. 2: 63 (1957). 78 Reinert, R. E.: Electroencephalographic changes with promazine. Amer. J. Psychiat. 115: 742 (1959). 79 Rickels, K., et al.: Evaluation of tranquilizing drugs in medical outpatients. Meprobamate, prochlorperazine, amobarbital sodium, and placebo. J.A.M.A. 171: 1649 (1959). 80 Rosenfeld, J. E., and Bizzocco, D. H.: A controlled study of alcohol withdrawal. Quart. J. Stud. Alc. 22(Suppl. 1): 77 (1961). 81 Rosenstein, I. N.: A new psychosedative (Librium) as an anticonvulsant in grand mal type convulsive seizure. Dis. Nerv. Syst. 21: 57 (1960). 82 Sainz, A. A.: The treatment of drug and and alcohol withdrawal effects with “Thorazine.” Psychiat. Quart. 31: 275 (1957). 83 Schultz, J. D.: Treatment of alcoholism in a general hospital. Quart. J. Stud. Alc. 22(Suppl. 1): 85 (1961). 84 Schultz, J. D., Rea, E. L., Fazekas, J. F., and Shea, J. C.: Chlorpromazine in the management of acute alcoholic states. Quart. J. Stud. Alc. 16: 245 (1955). 85 Schwartzberg, A. Z., and Van de Castle, R. W.: A controlled clinical study of chlordiazepoxide. Amer. J. Psychiat. 117: 922 (1961). 86 Shaffer, J. W., et al.: A controlled evaluation of chlordiazepoxide in the treatment of convalescing alcoholics. J. Nerv. Ment. Dis. 137: 494 (1963). 87 Smith, J. A., et al.: A comparison of phenaglycodol (Ultran), meprobamate and a placebo in abstinent alcoholics. Amer. J. Psychiat. 114: 364 (1957). 88 Smith, M. E., Evans, R. L., Newman, E. J., and Newman, H. W.: Psychotherapeutic agents and ethyl alcohol. Quart. J. Stud. Alc. 22: 241 (1961). 89 Speight, P. H.: Notes on the use of Librium in the treatment of alcoholism. Med. J. Australia 2: 741 (1960). 90 Thimann, J., and Gauthier, J. W.: Promazine-meprobamate compound: a medication in the treatment of alcohol addicts. Med. Times 89: 1035 (1961). 91 Ticktin, H. E., and Schultz, J. E.: Librium, a new quieting drug for the hyperactive alcoholic and psychotic patient. Dis. Nerv. Syst. 21 (Suppl.): 49 (1960). 92 Tobin, J. M., et al.: Preliminary evaluation of Librium in the treatment of anxiety reactions. Dis. Nerv. Syst. 21 (Suppl.): 11 (1960). 93 Turner, W. J., Krumholz, W. V., and Merlis, S.: The effects of Librium on the human electroencephalogram. Presented at the American Electroencephalographers' Society Meeting, Boston, June 1960. 94 Dickerson, D. L., et al. eds.: Symposium on diazepam. Western Med. 4(Suppl.): 3 (1963). 95 Ungerleider, J. T.: Alcohol, convulsions and tranquilizers: a clinical and electroencephalographic study. J. Nerv. Ment. Dis. 127: 518 (1958). 96 Valium. Medical Letter 6: 17 (1963). 97 Watson, C. W., Bowker, R., and Calish, C.: Effects of chlordiazepoxide on epileptic seizures. J.A.M.A. 188: 212 (1964). 98 Winfield, D. L., and Aivazian, G. H.: Librium therapy and electroencephalographic correlates. J. Nerv. Ment. Dis. 133: 240 (1961). 99 Zbinden, G., et al.: Experimental and clinical toxicology of chlordiazepoxide. Tox. & Appl. Pharm. 3: 619 (1961). 100 Zirkle, G. A., King, P. D., McAtee, O. G., and VanDyke, R.: Effects of chlorpromazine and alcohol on coordination and judgment. J.A.M.A. 171: 1496 (1959). 101 Zirkle, G. A., McAtee, O. B., King, P. D., and VanDyke, R.: Meprobamate and small amounts of alcohol: effects on human ability, coordination and judgment. J.A.M.A. 173: 1823 (1960). Citing Literature Volume7, Issue1January‐February 1967Pages 17-25 ReferencesRelatedInformation" @default.
• W2017459623 created "2016-06-24" @default.
• W2017459623 creator A5038711915 @default.
• W2017459623 creator A5075105047 @default.
• W2017459623 date "1967-01-02" @default.
• W2017459623 modified "2023-09-27" @default.
• W2017459623 title "Tranquilizers in the Management of Alcoholics: A Review of the Literature to 1964. Part II" @default.
• W2017459623 cites W1433242899 @default.
• W2017459623 cites W1965459069 @default.
• W2017459623 cites W1966794800 @default.
• W2017459623 cites W1967616565 @default.
• W2017459623 cites W1972432671 @default.
• W2017459623 cites W1972447253 @default.
• W2017459623 cites W1972521964 @default.
• W2017459623 cites W1975979048 @default.
• W2017459623 cites W1984430927 @default.
• W2017459623 cites W1988994570 @default.
• W2017459623 cites W1996093048 @default.
• W2017459623 cites W2003187091 @default.
• W2017459623 cites W2010211077 @default.
• W2017459623 cites W2010272406 @default.
• W2017459623 cites W2010545337 @default.
• W2017459623 cites W2011800515 @default.
• W2017459623 cites W2014494572 @default.
• W2017459623 cites W2025589467 @default.
• W2017459623 cites W2026687544 @default.
• W2017459623 cites W2031185404 @default.
• W2017459623 cites W2031244258 @default.
• W2017459623 cites W2033588605 @default.
• W2017459623 cites W2046011179 @default.
• W2017459623 cites W2047457312 @default.
• W2017459623 cites W2049570047 @default.
• W2017459623 cites W2058706760 @default.
• W2017459623 cites W2061564163 @default.
• W2017459623 cites W2066670542 @default.
• W2017459623 cites W2068377394 @default.
• W2017459623 cites W2072927340 @default.
• W2017459623 cites W2073981924 @default.
• W2017459623 cites W2084577789 @default.
• W2017459623 cites W2094674650 @default.
• W2017459623 cites W2095212337 @default.
• W2017459623 cites W2100288525 @default.
• W2017459623 cites W2100785768 @default.
• W2017459623 cites W2145267190 @default.
• W2017459623 cites W2146182933 @default.
• W2017459623 cites W2152756968 @default.
• W2017459623 cites W2312362483 @default.
• W2017459623 cites W2313889289 @default.
• W2017459623 cites W2320947113 @default.
• W2017459623 cites W2406013635 @default.
• W2017459623 cites W2406155178 @default.
• W2017459623 cites W2410555575 @default.
• W2017459623 cites W2416529182 @default.
• W2017459623 cites W2473527819 @default.
• W2017459623 cites W2474520499 @default.
• W2017459623 cites W2976309305 @default.
• W2017459623 cites W3018938307 @default.
• W2017459623 cites W3019454934 @default.
• W2017459623 cites W2318002250 @default.
• W2017459623 doi "https://doi.org/10.1002/j.1552-4604.1967.tb00025.x" @default.
• W2017459623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/5341415" @default.
• W2017459623 hasPublicationYear "1967" @default.
• W2017459623 type Work @default.
• W2017459623 sameAs 2017459623 @default.
• W2017459623 citedByCount "4" @default.
• W2017459623 crossrefType "journal-article" @default.
• W2017459623 hasAuthorship W2017459623A5038711915 @default.
• W2017459623 hasAuthorship W2017459623A5075105047 @default.
• W2017459623 hasConcept C118552586 @default.
• W2017459623 hasConcept C71924100 @default.
• W2017459623 hasConceptScore W2017459623C118552586 @default.
• W2017459623 hasConceptScore W2017459623C71924100 @default.
• W2017459623 hasIssue "1" @default.
• W2017459623 hasLocation W20174596231 @default.
• W2017459623 hasLocation W20174596232 @default.
• W2017459623 hasOpenAccess W2017459623 @default.
• W2017459623 hasPrimaryLocation W20174596231 @default.
• W2017459623 hasRelatedWork W1506200166 @default.
• W2017459623 hasRelatedWork W1995515455 @default.
• W2017459623 hasRelatedWork W2039318446 @default.
• W2017459623 hasRelatedWork W2048182022 @default.
• W2017459623 hasRelatedWork W2080531066 @default.
• W2017459623 hasRelatedWork W2748952813 @default.
• W2017459623 hasRelatedWork W2899084033 @default.
• W2017459623 hasRelatedWork W3031052312 @default.
• W2017459623 hasRelatedWork W3032375762 @default.
• W2017459623 hasRelatedWork W3108674512 @default.
• W2017459623 hasVolume "7" @default.
• W2017459623 isParatext "false" @default.
• W2017459623 isRetracted "false" @default.
• W2017459623 magId "2017459623" @default.
• W2017459623 workType "article" @default.